Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Cell Death Diagnostics Allowing Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies

NCT06928649 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT06928649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06928649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Cell Death Diagnostics Allowing Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies
Lead sponsor
University Hospital, Antwerp
Phase
Not applicable
Overall status
Recruiting
Start date
March 13, 2024
Completion date
August 31, 2026
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, subarachnoid haemorrhage (sah), trauma related injuries